CTRI/2009/091/001067已完成3 期
AN OPEN LABEL, RANDOMIZED, PARALLEL GROUP, PROSPECTIVE, MULTICENTRE CLINICAL TRIAL FOR EVALUATION OF EFFICACY AND SAFETY OF IN-PHARM-002 IN COMPARISON WITH IBUPROFEN IN ADULT PATIENTS WITH ACUTE PAINFUL SOFT TISSUE INJURY
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 204
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •(1)Patients of either sex between 18 and 60 years of age diagnosed with acute painful soft tissue injury.
- •(2)Subjects willing to provide written informed consent
- •In case of female with child bearing potential Surgically sterile or using a medically accepted means of contraception with negative serum pregnancy test
排除标准
- •(1)Concomitant peptic ulcer, gastrointestinal bleeding and asthma.
- •(2)Serious heart, blood, renal or hepatic diseases.
- •(3)Clinically significant abnormalities on physical examination or laboratory tests.
- •(4)Ongoing use of prohibited medications [i.e. other NSAIDs, opioid analgesics and systemic corticosteroids].
- •(5)Pregnancy or lactation.
- •(6)As deemed inappropriate for enrollment by investigating physician due to other reasons.
研究者
相似试验
已完成
3 期
6-WEEK TRIAL OF THE EFFICACY AND SAFETY OF ASENAPINE COMPARED TO RISPERIDONE IN ADULT PATIENT WITH ACUTE EXACERBATION OF SCHIZOPHRENIACTRI/2010/091/000423Intas Pharmaceuticals Limited280
Unknown
3 期
13-WEEK STUDY FOR EVALUATION OF EFFICACY AND SAFETY OF IN-AQUL-002 TABLET COMPARED TO OXCARBAZEPINE SUSTAINED-RELEASE TABLET AS ADJUNCTIVE TREATEMENT IN ADULT PATIENTS WITH REFRACTORY PARTIAL-ONSET SEIZURESCTRI/2010/091/006085Intas Pharmaceuticals Limited270
Unknown
3 期
PHASE III CLINICAL TRIAL FOR EVALUATION OF EFFICACY AND SAFETY OF IN-PHRM-001 IN COMPARISON WITH ALLOPURINOL IN ADULT PATIENTS WITH GOUT.CTRI/2009/091/001087Intas Pharmaceuticals Limited270
已完成
3 期
CLINICAL TRIAL FOR EVALUATION OF EFFICACY AND SAFETY OF PRASUGREL IN COMPARISON WITH CLOPIDOGREL IN ACUTE CORONARY SYNDROME (ACS) PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI).CTRI/2009/091/001085Intas Pharmaceuticals Limited240
尚未招募
2 期
A clinical study to evaluate effectiveness of Unani formulations in TineaCTRI/2020/04/024765ational Research Institute of Unani Medicine for Skin Disorders